Sequent nails down $26M for aneurysm treatment device; Stroke patients getting too many scans;

> Sequent Medical has nailed down $26 million in Series C venture financing to fund continued development of its WEB aneurysm embolization system. Release

> Molecular Detection has raised $1.5 million in new financing to advance its molecular diagnostics tests for sepsis and gastrointestinal disease. Release

> Stroke patients are getting both CT and MRI scans when they should just be receiving the more accurate second option on its own. And the redundancy is driving up healthcare costs, according to a University of Michigan study. Release

> The FDA will begin to collect medical device information for its Emergency Shortages Data Collections System. Story

And Finally... Diabetes patient Laura Ritchie lost consciousness while her foot was under a hot tap for 6 hours and suffered horrific burns. But she is on the mend thanks to a "spray-on skin." Doctors are now hopeful her wound may one day heal. Story

Suggested Articles

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.